FN1 and liver cancer: On the other hand, as shown in Figure 4B, we carried out an adhesion inhibition experiment using anti-αv (P2W7) and anti-β3 (BV4) mAb at different concentrations (6, 12, 25 and 50 μg/ml) to verify the type of integrin that mediates adhesion of liver cancer cells to FN.